Anoikis

Detachment first disrupts integrin-mediated signaling. This can reduce activity through focal adhesion kinase and PI3K-AKT pathways, shifting the balance of Bcl-2 family proteins toward mitochondrial dysfunction. That change then promotes activation of executioner caspases, the enzymes that carry out much of the cell death program. Tracking these linked events connects physical detachment with the biochemical decision to die.

The Bcl-2 family balance acts as a control point between disrupted adhesion signals and mitochondrial dysfunction. When detachment shifts this balance in a pro-death direction, mitochondrial failure becomes part of the pathway leading to executioner caspase activation. This position makes Bcl-2 family regulation important for understanding why some detached cells die while resistant cells persist.

Anoikis resistance allows tumor cells to survive after losing appropriate attachment-dependent signals, rather than undergoing the death response associated with detachment. In cancer biology, that persistence can support survival in circulation, colonization of distant organs, and resistance to therapy. Comparing sensitive and resistant cells therefore links a cell-survival phenotype to metastatic behavior.

An informative study can connect three levels: the cell’s attachment state, the status of integrin-linked focal adhesion kinase and PI3K-AKT signaling, and downstream mitochondrial dysfunction or executioner caspase activation. Linking these observations helps determine whether altered survival reflects the attachment response itself and provides a mechanistic basis for evaluating resistance to anoikis.

Within epithelial homeostasis and tissue remodeling, anoikis removes cells that no longer receive appropriate matrix attachment signals. This supports tissue organization by limiting survival outside a suitable structural context. Studying the process in these settings can therefore clarify how cell loss contributes to maintenance and remodeling, rather than treating cell death as an isolated event.

Measuring anoikis can reveal whether a cancer cell population remains dependent on attachment-linked survival signals or includes cells resistant to detachment-induced death. Results can connect changes in focal adhesion kinase and PI3K-AKT signaling, Bcl-2 family balance, mitochondrial dysfunction, and executioner caspase activation with metastatic potential. This makes the measurement useful for identifying survival mechanisms and possible therapeutic targets.